For patients at high risk for fracture due to osteoporosis
FORTEO (teriparatide injection) can help reduce your risk of having another fracture*
FORTEO is a prescription medicine used to treat postmenopausal women who have osteoporosis who are at high risk for having broken bones (fractures) or who cannot use other osteoporosis treatments. FORTEO can lessen the chance of broken bones (fractures) in the spine and other bones in postmenopausal women with osteoporosis. FORTEO is used to increase the bone mass in men with primary or hypogonadal osteoporosis who are at high risk for having broken bones (fractures) or who cannot use other osteoporosis treatments. FORTEO is used to treat both men and women with osteoporosis due to use of glucocorticoid medicines, such as prednisone, for several months, who are at high risk for having broken bones (fractures) or who cannot use other osteoporosis treatments.
*Only proven in postmenopausal women with osteoporosis. All women took calcium and vitamin D daily.
Here is some important safety information you should know about FORTEO:
Possible bone cancer. During drug testing, the medicine in FORTEO caused some rats to develop a bone cancer called osteosarcoma. Studies in people have not shown that FORTEO increases your chance of getting osteosarcoma. There is little information about the chance of getting osteosarcoma in patients using FORTEO beyond 2 years.
Start managing your osteoporosis with FORTEO
Consult your healthcare provider to determine if FORTEO is right for you.
‡FDA approval in 2002
§Cumulative worldwide exposure through 31 August 2017 across all approved indications.
FORTEO Connect™ is available for support
Joining FORTEO Connect™ provides access to a team of professionals committed to helping you get off to a good start. Support includes:
- FORTEO information and injection training
- Insurance investigation